[Form 4] Astera Labs, Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Astera Labs, Inc. director and CEO Mohan Jitendra reported that a living trust associated with him sold 335,881 shares of Common Stock in open-market transactions. The sales occurred on April 17 and April 20, 2026 at weighted average prices generally in the high $160s to mid-$170s per share.
The transactions were executed automatically under a Rule 10b5-1 trading plan adopted on December 1, 2025. The filing notes that the shares are held by a living trust and other estate planning trusts, and Jitendra disclaims beneficial ownership of these securities except to the extent of any pecuniary interest, while still reporting more than 4.3 million shares held indirectly after the sales.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 335,881 shares ($57,852,785)
Net Sell
16 txns
Insider
Mohan Jitendra
Role
Chief Executive Officer
Sold
335,881 shs ($57.85M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 6,526 | $175.2413 | $1.14M |
| Sale | Common Stock | 3,662 | $175.8102 | $644K |
| Sale | Common Stock | 17,856 | $167.9544 | $3.00M |
| Sale | Common Stock | 29,085 | $168.7772 | $4.91M |
| Sale | Common Stock | 35,384 | $169.8048 | $6.01M |
| Sale | Common Stock | 39,276 | $170.7653 | $6.71M |
| Sale | Common Stock | 32,172 | $171.8146 | $5.53M |
| Sale | Common Stock | 19,281 | $172.6746 | $3.33M |
| Sale | Common Stock | 107,608 | $174.0616 | $18.73M |
| Sale | Common Stock | 45,031 | $174.4295 | $7.85M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 4,072,796 shares (Indirect, By Living Trust);
Common Stock — 1,452,739 shares (Direct, null)
Footnotes (1)
- The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.2900 to $168.2800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.2900 to $169.2500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.2900 to $170.2800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.2900 to $171.2800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.2900 to $172.2800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $172.2900 to $173.2800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.2900 to $174.2800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $174.2850 to $174.8900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $174.5250 to $175.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $175.5525 to $176.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Key Figures
Shares sold: 335,881 shares
Sample sale price: $175.8102 per share
Lowest disclosed price range: $167.2900–$168.2800
+3 more
6 metrics
Shares sold
335,881 shares
Total open-market sales reported in Form 4
Sample sale price
$175.8102 per share
Weighted average price for 3,662-share sale on April 20, 2026
Lowest disclosed price range
$167.2900–$168.2800
Intraday range for one weighted-average sale block
Highest disclosed price range
$175.5525–$176.0500
Intraday range for another weighted-average sale block
Indirect holdings after sales
More than 4.3 million shares
Indirect Common Stock holdings shown after reported transactions
Rule 10b5-1 plan adoption date
December 1, 2025
Date CEO adopted pre-set trading plan governing these sales
Key Terms
Rule 10b5-1 trading plan, weighted average price, estate planning trust, pecuniary interest, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
estate planning trust financial
"These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership..."
pecuniary interest financial
"The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein..."
beneficial ownership regulatory
"The filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
